secwatch.observer — SEC 8-K summary
======================================

Issuer:     Longevity Health Holdings, Inc. (XAGE)
CIK:        0001842939
Form:       8-K
Filed at:   2023-07-20T23:59:59+00:00
Accession:  0001193125-23-190559
Event type: m_and_a
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 2.01, 5.06, 9.01, 5.02, 3.02, 4.01, 3.03, 5.01, 5.03, 5.05, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Carmell Therapeutics completes de-SPAC merger; $129.4M redeemed, 19.2M shares outstanding
--------------------------------------------------------------------------------

- Business combination closed July 14, 2023; ALPA renamed to Carmell Therapeutics (CTCX).
- 12.6M shares redeemed at $10.00 each, depleting ~$129.4M from trust.
- Post-merger shares outstanding: 19,236,305; top holder AHAC Sponsor III LLC holds 19.68%.
- Rajiv Shukla appointed Executive Chairman; one-year lock-up for certain stockholders, sponsor faces 5-year lock-up on 50% of founder shares.
- Indemnification agreements and 2023 Long-Term Incentive Plan adopted; warrants trade under CTCXW.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1842939/000119312523190559/0001193125-23-190559-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1842939/000119312523190559/d513602d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-190559

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer